Presently, only the Amaryllidaceae alkaloid galanthamine, an acetylcholinesterase inhibitor used to treat symptoms of Alzheimer’s disease, is produced commercially as a drug from cultivated plants. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.